关注
JW Feng
JW Feng
在 google.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitors
ST Staben, JA Feng, K Lyle, M Belvin, J Boggs, JD Burch, C Chua, H Cui, ...
Journal of medicinal chemistry 57 (3), 1033-1045, 2014
712014
The crystal structure of the catalytic domain of the NF-κB inducing kinase reveals a narrow but flexible active site
G de Leon-Boenig, KK Bowman, JA Feng, T Crawford, C Everett, ...
Structure 20 (10), 1704-1714, 2012
702012
Structure-based design of tricyclic NF-κB inducing kinase (NIK) inhibitors that have high selectivity over phosphoinositide-3-kinase (PI3K)
GM Castanedo, N Blaquiere, M Beresini, B Bravo, H Brightbill, J Chen, ...
Journal of medicinal chemistry 60 (2), 627-640, 2017
622017
Conformational manifold of α-aminoisobutyric acid (Aib) containing alanine-based tripeptides in aqueous solution explored by vibrational spectroscopy, electronic circular …
R Schweitzer-Stenner, W Gonzales, GT Bourne, JA Feng, GR Marshall
Journal of the American Chemical Society 129 (43), 13095-13109, 2007
552007
Compounds, compositions and methods
AA Estrada, JA Feng, B Fox, CP Leslie, JP Lyssikatos, A Pozzan, ...
US Patent 9,815,850, 2017
522017
Measuring experimental cyclohexane-water distribution coefficients for the SAMPL5 challenge
AS Rustenburg, J Dancer, B Lin, JA Feng, DF Ortwine, DL Mobley, ...
Journal of computer-aided molecular design 30, 945-958, 2016
522016
Scaffold-hopping approach to discover potent, selective, and efficacious inhibitors of NF-κB inducing kinase
N Blaquiere, GM Castanedo, JD Burch, LM Berezhkovskiy, H Brightbill, ...
Journal of Medicinal Chemistry 61 (15), 6801-6813, 2018
442018
Optimizing active learning for free energy calculations
J Thompson, WP Walters, JA Feng, NA Pabon, H Xu, M Maser, ...
Artificial Intelligence in the Life Sciences 2, 100050, 2022
352022
6, 5-Heterocyclic propargylic alcohol compounds and uses therefor
S Staben, J Feng, PL Loke, CAGN Montalbetti
US Patent 8,901,313, 2014
332014
Development of potent and selective pyrazolopyrimidine IRAK4 inhibitors
MC Bryan, J Drobnick, A Gobbi, A Kolesnikov, Y Chen, N Rajapaksa, ...
Journal of Medicinal Chemistry 62 (13), 6223-6240, 2019
242019
An integrated suite of modeling tools that empower scientists in structure-and property-based drug design
JA Feng, I Aliagas, P Bergeron, JM Blaney, EK Bradley, MFT Koehler, ...
Journal of Computer-Aided Molecular Design 29, 511-523, 2015
212015
SKATE: a docking program that decouples systematic sampling from scoring
JA Feng, GR Marshall
Journal of computational chemistry 31 (14), 2540-2554, 2010
202010
chemalot and chemalot_knime: Command line programs as workflow tools for drug discovery
ML Lee, I Aliagas, JA Feng, T Gabriel, TJ O’donnell, BD Sellers, ...
Journal of cheminformatics 9, 1-14, 2017
192017
A second look at mini-protein stability: Analysis of FSD-1 using circular dichroism, differential scanning calorimetry, and simulations
JA Feng, J Kao, GR Marshall
Biophysical journal 97 (10), 2803-2810, 2009
172009
DEGAS: sharing and tracking target compound ideas with external collaborators
ML Lee, I Aliagas, J Dotson, JA Feng, A Gobbi, T Heffron
Journal of chemical information and modeling 52 (2), 278-284, 2012
152012
Compounds, compositions and methods
AA Estrada, JA Feng, B Fox, ZK Sweeney
US Patent 9,896,458, 2018
142018
Compounds, compositions, and methods
AA Estrada, JA Feng, JP Lyssikatos, ZK Sweeney, J de Vicente Fidalgo
US Patent 9,932,325, 2018
112018
Compounds, compositions, and methods
AA Estrada, JA Feng, JP Lyssikatos, ZK Sweeney, J de Vicente Fidalgo
US Patent App. 15/624,566, 2017
112017
Chimeric protein engineering
JA Feng, LA Tessler, GR Marshall
International Journal of Peptide Research and Therapeutics 13, 151-160, 2007
102007
Compounds, compositions and methods
AA Estrada, JA Feng, B Fox, CP Leslie, JP Lyssikatos, A Pozzan, ...
US Patent 10,131,676, 2018
82018
系统目前无法执行此操作,请稍后再试。
文章 1–20